简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
B&K CORP-B
B&K CORP-B (02396.HK): Chinese Corporate Name Changed from Huaren Bio-B to Qingcheng New Drug-B, New Stock Short Name Effective from 22 July
Tags:
B&K CORP-B
02396.HK
Corporate Name Change
2026-07-17
Featured News
Finance
Deepexi Technology(01384.HK): Positive Performance Forecast, Interim Revenue Expected to Surge 101% to 120%
Finance
WebX Holding Group(00339.HK): Resignation of Directors and Appointment of Independent Non-executive Director
Finance
China Resources Building Materials Technology (01313.HK): Profit Warning, Interim Loss Attributable to Owners Expected at RMB 400 Million to 500 Million
Finance
Sinotrans (00598.HK): Board Director Changes, Yang Guofeng Resigns, Li Feng and Sun Jianfeng Nominated
Finance
HJ Science(06132.HK): Stabilisation Period Ends, Over-allotment Option Lapses
Research
Autonomous Driving Concept Stocks Watch | XPENG-W(09868.HK) Trades Weaker in Afternoon; Local Acceptance Test of Turing AI Intelligent Driving Completed in Germany
Finance
Yongda Automobiles Services Holdings(03669.HK): Chairman & Executive Director Zhang De'an Acquires Additional 2 Million Shares
Finance
UBTECH (09880.HK): Completes Full Circulation of H Shares
Finance
Carote (02549.HK): Positive Profit Forecast, Interim Revenue and Net Profit Expected to Rise 30% to 35%
Finance
Kaisa Capital (00936.HK): Appointment of Song Wei as Executive Director
Scan QR Code
Download App